Nephros, Inc. (NEPH) Stock Score, Valuation & Financial Research
Nephros, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 49/100.
Quick answer for NEPH
Nephros, Inc. currently has a Wall Street Score of 49/100. The stored market price is $4.47. Its financial score is 40/100. Its valuation score is 25/100. These figures are a research snapshot, not a buy or sell recommendation.
What Nephros, Inc. does
Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products. These are vital in dialysis centers for eradicating biological contaminants from water and bicarbonate concentrate, and are also deployed in hospitals to prevent infections from waterborne pathogens such as Legionella and Pseudomonas. Their utility extends to military installations, outdoor recreation, commercial establishments, and various other healthcare facilities. The Pathogen Detection segment focuses on developing and distributing real-time water testing systems, which deliver critical, ac
NEPH financial snapshot
- Wall Street Score:
- 49/100
- Current price:
- $4.47
- Market capitalization:
- $48.5M
- Revenue:
- $19.1M
- Net income:
- $776K
- Free cash flow:
- $1.6M
- Cash:
- $4.0M
- Total debt:
- $968K
- EPS:
- 0.11
- P/E ratio:
- 40.6x
- Financial score:
- 40/100
- Valuation score:
- 25/100
- Revenue score:
- 22/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $1.6M, showing positive cash generation.
- The balance sheet shows $4.0M of cash versus $968K of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 25/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 40/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research NEPH
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.